Cargando…
Emerging proteomics biomarkers and prostate cancer burden in Africa
Various biomarkers have emerged via high throughput omics-based approaches for use in diagnosis, treatment, and monitoring of prostate cancer. Many of these have yet to be demonstrated as having value in routine clinical practice. Moreover, there is a dearth of information on validation of these eme...
Autores principales: | Adeola, Henry A., Blackburn, Jonathan M., Rebbeck, Timothy R., Zerbini, Luiz F. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5514967/ https://www.ncbi.nlm.nih.gov/pubmed/28388542 http://dx.doi.org/10.18632/oncotarget.16568 |
Ejemplares similares
-
Novel potential serological prostate cancer biomarkers using CT100+ cancer antigen microarray platform in a multi-cultural South African cohort
por: Adeola, Henry A., et al.
Publicado: (2016) -
The Prospect and Challenges to the Flow of Liquid Biopsy in Africa
por: Temilola, Dada Oluwaseyi, et al.
Publicado: (2019) -
Promise and Implementation of Proteomic Prostate Cancer Biomarkers
por: Latosinska, Agnieszka, et al.
Publicado: (2018) -
The Burden of Truncus Arteriosus in an Urban City in Africa: How are we Fairing?
por: Animasahun, Barakat Adeola, et al.
Publicado: (2017) -
Emerging biomarkers in the diagnosis of prostate cancer
por: Filella, Xavier, et al.
Publicado: (2018)